Mutaflor ® – the probiotic pharmaceutical with E. coli strain Nissle 1917. Introduction and summary; Pharmaceutical forms; Indications and dosage; Storage information; Medicinal …

Mutaflor, first isolated in 1917, is a probiotic comprising of a viable non-pathogenic bacteria strain named Escherichia coli Nissle 1917. Over the last century it has shown through clinical studies …

Current registrations, clinical studies and casuistics demonstrate the broad range of ­Mutaflor applications. This reaches from chronic bowel diseases to the colonization prophylaxis of …

Mutaflor® is a remedy for the treatment of gut diseases. The bacterium Escherichia coli (E. coli) strain Nissle 1917 – the active substance of Mutaflor® – is a natural colonizer of the gut. On its …

Mutaflor® Escherichia coli strain Nissle 1917 (EcN) is arguably one of the best studied and field tested probiotic strains and fulfills all the demanding criteria and characteristics required for a …

Escherichia coli Nissle 1917 (Mutaflor) is one of the most investigated probiotic bacteria. While the number of reports discussing the underlying mechanisms of Mutaflor has increased rapidly in …

2012年3月1日 · Mutaflor® is a natural colonizer of the gut. E.coli strain Nissle 1917 is a normal, non-pathogenic and non-invasive inhabitant of the human gut. By means of special adhesive …

1. What MUTAFLOR® is and what it is used for 1.1 Pharmacotherapeutic group and mode of action MUTAFLOR® is a remedy for the treatment of gut diseases. The bacterium Escherichia …

The name Mutaflor®, deduced from the Latin words mutare and flora to express the capability of the E.coli strain to change the intestinal microbiota by its antagonistic properties and at the …

Mutaflor ® – with the unique probiotic active ingredient Escherichia coli strain Nissle 1917 for human gut health. Current registrations, clinical studies and casuistics demonstrate the broad …